{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:39:15Z","timestamp":1772217555311,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1012730325902","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T09:27:29Z","timestamp":1040635649000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Thrombophilia and its Treatment in Pregnancy"],"prefix":"10.1007","volume":"12","author":[{"given":"Amiram","family":"Eldor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,9,1]]},"reference":[{"key":"359721_CR1","first-page":"403","volume":"11","author":"IA Greer","year":"1997","unstructured":"Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo\u2013embolism in obstetrics and gynaecology. Clin Obstet Gynaecol 1997;11:403\u2013430.","journal-title":"Clin Obstet Gynaecol"},{"key":"359721_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","volume":"353","author":"IA Greer","year":"1999","unstructured":"Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258\u20131265.","journal-title":"Lancet"},{"key":"359721_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bmj.1.5901.215","volume":"2","author":"MA Barracco","year":"1974","unstructured":"Barracco MA, Vessey M. Recurrence of venous thromboembolism and the use of oral contraceptives. Br Med J 1974;2:215.","journal-title":"Br Med J"},{"key":"359721_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1471-0528.1997.tb11043.x","volume":"104","author":"NS Macklon","year":"1997","unstructured":"Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol 1997;104:191\u2013197.","journal-title":"Br J Obstet Gynaecol"},{"key":"359721_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1055\/s-0038-1648485","volume":"67","author":"JS Ginsberg","year":"1992","unstructured":"Ginsberg JS, Brill\u2013Edwards P, Burrows RF, et al. Venous thrombosis during pregnancy: leg and trimester of presentation. Thromb Haemost 1992;67:519\u2013520.","journal-title":"Thromb Haemost"},{"key":"359721_CR6","volume-title":"Report on confi\u2013dential enquiries into maternal death in England and Wales 1982\u20131984","author":"A Turnball","year":"1989","unstructured":"Turnball A, Tindall VR, Beard RW. Report on confi\u2013dential enquiries into maternal death in England and Wales 1982\u20131984. London: HMSO 1989; Report No. 28."},{"key":"359721_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJM200002103420610","volume":"342","author":"IA Greer","year":"2000","unstructured":"Greer IA. The challenge of thrombophilia in maternalfetal medicine. N Engl J Med 2000;342:424\u2013425.","journal-title":"N Engl J Med"},{"key":"359721_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-0038-1657542","volume":"78","author":"U Seligsohn","year":"1997","unstructured":"Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997;78:297\u2013301.","journal-title":"Thromb Haemost"},{"key":"359721_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1056\/NEJM200002103420602","volume":"342","author":"A Gerhardt","year":"2000","unstructured":"Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and Factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374\u2013380.","journal-title":"N Engl J Med"},{"key":"359721_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/07853899509031957","volume":"27","author":"B Dahlback","year":"1995","unstructured":"Dahlback B. Molecular genetics of venous thromboembolism. Ann Med 1995;27:187\u2013192.","journal-title":"Ann Med"},{"key":"359721_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-0038-1645218","volume":"63","author":"J Conard","year":"1990","unstructured":"Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost 1990;63:319\u2013320.","journal-title":"Thromb Haemost"},{"key":"359721_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1055\/s-0038-1642528","volume":"71","author":"SV De","year":"1994","unstructured":"De SV, Leone G, Mastrangelo S, et al. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994;71:799\u2013800.","journal-title":"Thromb Haemost"},{"key":"359721_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1055\/s-0037-1615057","volume":"79","author":"P Clark","year":"1998","unstructured":"Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166\u20131170.","journal-title":"Thromb Haemost"},{"key":"359721_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk Factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111\u2013113.","journal-title":"Nat Genet"},{"key":"359721_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0002-9378(97)70617-3","volume":"176","author":"M Hallak","year":"1997","unstructured":"Hallak M, Senderowicz J, Cassel A, et al. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am J Obstet Gynecol 1997;176:889\u2013893.","journal-title":"Am J Obstet Gynecol"},{"key":"359721_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2141.1996.d01-1496.x","volume":"92","author":"MI Bokarewa","year":"1996","unstructured":"Bokarewa MI, Bremme K, Blomback M. Arg506\u2013Gln mutation in Factor V and risk of thrombosis during pregnancy. Br J Haematol 1996;92:473\u2013477.","journal-title":"Br J Haematol"},{"key":"359721_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1471-0528.2000.tb13281.x","volume":"107","author":"MD McColl","year":"2000","unstructured":"McColl MD, Ellison J, Reid F, Tait RC, Walker ID, Greer IA. Prothrombin 20210 G \u2192 A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol 2000;107:565\u2013569.","journal-title":"Br J Obstet Gynaecol"},{"key":"359721_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0037-1614222","volume":"79","author":"PG Lindqvist","year":"1998","unstructured":"Lindqvist PG, Svensson PJ, Dahlback B, Marsal K. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss\u2014a possible evolutionary selection mechanism. Thromb Haemost 1998;79:69\u201373.","journal-title":"Thromb Haemost"},{"key":"359721_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M den Heijer","year":"1996","unstructured":"den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep\u2013vein thrombosis. N Engl J Med 1996;334:759\u2013762.","journal-title":"N Engl J Med"},{"key":"359721_CR20","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.51.6.1622","volume":"51","author":"DJ Lanska","year":"1998","unstructured":"Lanska DJ, Kryscio RJ. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 1998;51:1622\u20131628.","journal-title":"Neurology"},{"key":"359721_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004150050224","volume":"245","author":"JL Mas","year":"1998","unstructured":"Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J Neurol 1998;245:305\u2013313.","journal-title":"J Neurol"},{"key":"359721_CR22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJM199609123351102","volume":"335","author":"SJ Kittner","year":"1996","unstructured":"Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768\u2013774.","journal-title":"N Engl J Med"},{"key":"359721_CR23","first-page":"462","volume":"2","author":"G Ruiz\u2013Irastorza","year":"2000","unstructured":"Ruiz\u2013Irastorza G, Khamashta MA, Hughes GRV. Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management. Israel Med Assoc J (IMAJ) 2000;2:462\u2013469.","journal-title":"Israel Med Assoc J (IMAJ)"},{"key":"359721_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.55.2.269","volume":"55","author":"C Lamy","year":"2000","unstructured":"Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology 2000;55:269\u2013274.","journal-title":"Neurology"},{"key":"359721_CR25","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJM199806183382502","volume":"338","author":"I Martinelli","year":"1998","unstructured":"Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral\u2013vein thrombosis in carriers of a prothrombin\u2013gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338:1793\u20131797.","journal-title":"N Engl J Med"},{"key":"359721_CR26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.STR.31.4.892","volume":"31","author":"MJ Kupferminc","year":"2000","unstructured":"Kupferminc MJ, Yair D, Bornstein NM, Lessing JB, Eldor A. Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia. Stroke 2000;31:892\u2013895.","journal-title":"Stroke"},{"key":"359721_CR27","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0002-9378(95)91325-4","volume":"173","author":"CM Salafia","year":"1995","unstructured":"Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. Intrauterine growth restriction in infants of less than thirty\u2013two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 1995;173:1049\u20131057.","journal-title":"Am J Obstet Gynecol"},{"key":"359721_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM199901073400102","volume":"340","author":"MJ Kupferminc","year":"1999","unstructured":"Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9\u201313.","journal-title":"N Engl J Med"},{"key":"359721_CR29","first-page":"45","volume":"96","author":"MJ Kupferminc","year":"2000","unstructured":"Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000;96:45\u201349.","journal-title":"Obstet Gynecol"},{"key":"359721_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1471-0528.2000.tb13341.x","volume":"107","author":"EF van der Molen","year":"2000","unstructured":"van der Molen EF, Verbruggen B, Novakova I, Eskes TK, Monnens LA, Blom HJ. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. Br J Obstet Gynaecol 2000; 107:785\u2013791.","journal-title":"Br J Obstet Gynaecol"},{"key":"359721_CR31","first-page":"S54","volume":"52","author":"SE Vollsett","year":"1998","unstructured":"Vollsett SE, Bjorke\u2013Monsen AAL, Igrens LM. Plasma total homocysteine and previous pregnancies: the Hordaland homocysteine study. Proceedings of the 2nd International Symposium on Homocysteine. Neth J Med 1998;52:S54.","journal-title":"Neth J Med"},{"key":"359721_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1471-0528.1996.tb09887.x","volume":"103","author":"RS Rai","year":"1996","unstructured":"Rai RS, Regan L, Chitolie A, Donald JG, Cohen H. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol 1996;103:842\u2013844.","journal-title":"Br J Obstet Gynaecol"},{"key":"359721_CR33","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1055\/s-0038-1656110","volume":"77","author":"E Grandone","year":"1997","unstructured":"Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997;77:1052\u20131054.","journal-title":"Thromb Haemost"},{"key":"359721_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0002-9378(97)70205-9","volume":"177","author":"DS Dizon\u2013Townson","year":"1997","unstructured":"Dizon\u2013Townson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the Factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402\u2013405.","journal-title":"Am J Obstet Gynecol"},{"key":"359721_CR35","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1055\/s-0038-1656060","volume":"77","author":"E Grandone","year":"1997","unstructured":"Grandone E, Margaglione M, Colaizzo D, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997;77: 822\u2013824.","journal-title":"Thromb Haemost"},{"key":"359721_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-2141.1997.882901.x","volume":"97","author":"B Brenner","year":"1997","unstructured":"Brenner B, Mandel H, Lanir N, et al. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997;97:551\u2013554.","journal-title":"Br J Haematol"},{"key":"359721_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-0037-1614620","volume":"82","author":"B Brenner","year":"1999","unstructured":"Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82:6\u20139.","journal-title":"Thromb Haemost"},{"key":"359721_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1055\/s-0037-1613894","volume":"83","author":"B Brenner","year":"2000","unstructured":"Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693\u2013697.","journal-title":"Thromb Haemost"},{"key":"359721_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","volume":"348","author":"FE Preston","year":"1996","unstructured":"Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913\u2013916.","journal-title":"Lancet"},{"key":"359721_CR40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","volume":"128","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Miletich JP, Buring JE, et al. Factor V Leiden mutation as a risk Factor for recurrent pregnancy loss. Ann Intern Med 1998;128:1000\u20131003.","journal-title":"Ann Intern Med"},{"key":"359721_CR41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","volume":"81","author":"PG Lindqvist","year":"1999","unstructured":"Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999;81:532\u2013537.","journal-title":"Thromb Haemost"},{"key":"359721_CR42","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","volume":"343","author":"I Martinelli","year":"2000","unstructured":"Martinelli I, Taioli E, Cetin I, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015\u20131018.","journal-title":"N Engl J Med"},{"issue":"Suppl1","key":"359721_CR43","first-page":"118b","volume":"92","author":"SR Deitcher","year":"1998","unstructured":"Deitcher SR, Park VM, Kutteh WH. Prothrombin 20210 GA mutation analysis in Caucasian women with early first trimester recurrent pregnancy loss. Blood 1998;92(Suppl 1):118b.","journal-title":"Blood"},{"key":"359721_CR44","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0029-7844(00)00594-9","volume":"95","author":"CP Durnwald","year":"2000","unstructured":"Durnwald CP, Flora R, Agamanolis D, Spirtos N, Steele M, Galehouse D. Hereditary thrombophilia as a cause of fetal loss. Obstet Gynecol 2000;95:S11\u2013S12.","journal-title":"Obstet Gynecol"},{"key":"359721_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ajmg.1320450107","volume":"45","author":"V Wong","year":"1993","unstructured":"Wong V, Cheng CH, Chan KC. Fetal neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet 1993;45:17\u201321.","journal-title":"Am J Med Genet"},{"key":"359721_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S0022215100099011","volume":"100","author":"MS Zakzouk","year":"1986","unstructured":"Zakzouk MS. The congenital warfarin syndrome. J Laryngol Otol 1986;100:215\u2013219.","journal-title":"J Laryngol Otol"},{"issue":"3","key":"359721_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1055\/s-2007-1009401","volume":"19","author":"JG Weg","year":"1998","unstructured":"Weg JG. Venous thromboembolism in pregnancy. Semin Resp Crit Care Med 1998;19(3):231\u2013241.","journal-title":"Semin Resp Crit Care Med"},{"key":"359721_CR48","unstructured":"Eldor A. The treatment of thrombosis during pregnancy. Hematology 1999;(special issue):483\u2013490."},{"key":"359721_CR49","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","volume":"176","author":"C Nelson\u2013Piercy","year":"1997","unstructured":"Nelson\u2013Piercy C, Letsky EA, de Swiet M. Low\u2013molecular\u2013weight heparin for obstetric thromboprophylaxis: experience of sixty\u2013nine pregnancies in sixty\u2013one women at high risk. Am J Obstet Gynecol 1997;176:1062\u20131068.","journal-title":"Am J Obstet Gynecol"},{"key":"359721_CR50","doi-asserted-by":"publisher","first-page":"524S","DOI":"10.1378\/chest.114.5_Supplement.524S","volume":"114","author":"JS Ginsberg","year":"1998","unstructured":"Ginsberg JS, Hirsh J. Use of anticoagulants during pregnancy. Chest 1998;114(suppl):524S\u2013530S.","journal-title":"Chest"},{"key":"359721_CR51","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.1378\/chest.119.1_suppl.122S","volume":"119","author":"JS Ginsberg","year":"2001","unstructured":"Ginsberg JS, Greer IA, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119(suppl): 122S\u2013131S.","journal-title":"Chest"},{"key":"359721_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0020-7292(92)90261-G","volume":"39","author":"S Gillis","year":"1992","unstructured":"Gillis S, Shushan A, Eldor A. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. Int J Gynaecol Obstet 1992;39:297\u2013301.","journal-title":"Int J Gynaecol Obstet"},{"key":"359721_CR53","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1055\/s-0038-1646338","volume":"68","author":"E Melissari","year":"1992","unstructured":"Melissari E, Parker CJ, Wilson NV, et al. Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992;68:652\u2013656.","journal-title":"Thromb Haemost"},{"key":"359721_CR54","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00006254-199406000-00025","volume":"49","author":"MD Fejgin","year":"1994","unstructured":"Fejgin MD, Lourwood DL. Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv 1994;49:424\u2013431.","journal-title":"Obstet Gynecol Surv"},{"key":"359721_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0038-1655903","volume":"77","author":"BJ Hunt","year":"1997","unstructured":"Hunt BJ, Doughty HA, Majumdar G, et al. Thromboprophylaxis with low molecular weight heparin (fragmin) in high risk pregnancies. Thromb Haemost 1997;77:39\u201343.","journal-title":"Thromb Haemost"},{"key":"359721_CR56","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","volume":"176","author":"C Nelson\u2013Piercy","year":"1997","unstructured":"Nelson\u2013Piercy C, Letsky EA, De Swiet M. Low\u2013molecular\u2013weight heparin for obstetric thromboprophylaxis: experience of sixty\u2013nine pregnancies in sixty\u2013one women at high risk. Am J Obstet Gynecol 1997;176:1062\u20131068.","journal-title":"Am J Obstet Gynecol"},{"key":"359721_CR57","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1055\/s-0037-1614550","volume":"81","author":"BJ Sanson","year":"1999","unstructured":"Sanson BJ, Lensing AW, Prins MH, et al. Safety of low\u2013molecular\u2013weight heparin in pregnancy: a systematic review. Thromb Haemost 1999; 81:668\u2013672.","journal-title":"Thromb Haemost"},{"key":"359721_CR58","first-page":"314","volume":"23","author":"J Harenberg","year":"1993","unstructured":"Harenberg J, Schneider D, Heilmann L, Wolf H. Lack of anti\u2013factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis 1993;23:314\u2013320.","journal-title":"Haemostasis"},{"key":"359721_CR59","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1213\/00000539-199412000-00024","volume":"79","author":"EP Vandermeulen","year":"1994","unstructured":"Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal\u2013epidural anesthesia. Anesth Analg 1994;79:1165\u20131177.","journal-title":"Anesth Analg"},{"key":"359721_CR60","first-page":"147","volume":"19","author":"D Bergqvist","year":"1993","unstructured":"Bergqvist D, Lindblad B, Matsch T. Risk of combining low molecular weight heparin for thromboprophylaxis and epidural or spinal anesthesia. Semin Thromb Hemost 1993;19:147\u2013151.","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl2","key":"359721_CR61","first-page":"S91","volume":"10","author":"A Eldor","year":"1999","unstructured":"Eldor A. Applying risk assessment models in nonsurgical patients: effective risk stratification. Blood Coagul Fibrinolysis 1999;10(Suppl 2):S91\u2013S97.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"SupplS1","key":"359721_CR62","first-page":"98","volume":"29","author":"J Conard","year":"1999","unstructured":"Conard J, Horellou M, Samama MM. Management of pregnancy in women with thrombophilia. Haemostasis 1999;29(Suppl S1):98\u2013104.","journal-title":"Haemostasis"},{"key":"359721_CR63","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","volume":"343","author":"P Brill\u2013Edwards","year":"2000","unstructured":"Brill\u2013Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med 2000;343:1439\u20131444.","journal-title":"N Engl J Med"},{"key":"359721_CR64","first-page":"131","volume":"14","author":"F Lima","year":"1996","unstructured":"Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996;14:131\u2013136.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl2","key":"359721_CR65","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1177\/096120339800700221","volume":"7","author":"S Cowchock","year":"1998","unstructured":"Cowchock S. Treatment of antiphospholipid syndrome in pregnancy. Lupus 1998;7(Suppl 2):S95\u2013S97.","journal-title":"Lupus"},{"key":"359721_CR66","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1055\/s-0037-1615124","volume":"79","author":"BJ Hunt","year":"1998","unstructured":"Hunt BJ, Khamashta MA, Lakasing L, et al. Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: is warfarin preferable? Thromb Haemost 1998;79:1060\u20131061.","journal-title":"Thromb Haemost"},{"key":"359721_CR67","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM199803123381101","volume":"338","author":"S Caritis","year":"1998","unstructured":"Caritis S, Sibai B, Hauth J, et al. Low\u2013dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal\u2013Fetal Medicine Units. N Engl J Med 1998;338:701\u2013705.","journal-title":"N Engl J Med"},{"key":"359721_CR68","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","volume":"35","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody\u2013associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996;35:402\u2013407.","journal-title":"Am J Reprod Immunol"},{"key":"359721_CR69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653781","volume":"73","author":"JC Gris","year":"1995","unstructured":"Gris JC, Neveu S, Tailand ML, Courtieu C, Mares P, Schved JF. Use of low\u2013molecular\u2013weight heparin (enoxaparin) or of a phenformin\u2013like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity. Thromb Haemost 1995;73:362\u2013367.","journal-title":"Thromb Haemost"},{"key":"359721_CR70","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1055\/s-0037-1615890","volume":"82","author":"B Brenner","year":"1999","unstructured":"Brenner B. Inherited thrombophilia and pregnancy loss. Thromb Haemost 1999;82:634\u2013640.","journal-title":"Thromb Haemost"},{"key":"359721_CR71","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","volume":"107","author":"JS Younis","year":"2000","unstructured":"Younis JS, Ohel G, Brenner B, Haddad S, Lanir N, Ben\u2013Ami M. The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with Factor V Leiden mutation. Br J Obstet Gynaecol 2000;107:415\u2013419.","journal-title":"Br J Obstet Gynaecol"},{"key":"359721_CR72","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0020-7292(00)00202-2","volume":"69","author":"J Bar","year":"2000","unstructured":"Bar J, Cohen\u2013Sacher B, Hod M, Blickstein D, Lahav J, Merlob P. Low\u2013molecular\u2013weight heparin for thrombophilia in pregnant women. Int J Gynaecol Obstet 2000;69:209\u2013213.","journal-title":"Int J Gynaecol Obstet"},{"key":"359721_CR73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10641950109152640","volume":"20","author":"MJ Kupferminc","year":"2001","unstructured":"Kupferminc MJ, Fait G, Many A, et al. Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypertension in Pregnancy 2001;20:35\u201344.","journal-title":"Hypertension in Pregnancy"},{"key":"359721_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","volume":"80","author":"N Riyazi","year":"1998","unstructured":"Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA. Low\u2013molecular\u2013weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 1998;80:49\u201354.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"359721_CR75","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","volume":"174","author":"WH Kutteh","year":"1996","unstructured":"Kutteh WH. Antiphospholipid antibody\u2013associated recurrent pregnancy loss: treatment with heparin and low\u2013dose aspirin is superior to low\u2013dose aspirin alone. Am J Obstet Gynecol 1996;174:1584\u20131589.","journal-title":"Am J Obstet Gynecol"},{"key":"359721_CR76","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","volume":"314","author":"R Rai","year":"1997","unstructured":"Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997;314:253\u2013257.","journal-title":"Br Med J"},{"key":"359721_CR77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","volume":"182","author":"DW Branch","year":"2000","unstructured":"Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo\u2013controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000;182:122\u2013127.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012730325902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1012730325902\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012730325902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:21:27Z","timestamp":1754637687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1012730325902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["359721"],"URL":"https:\/\/doi.org\/10.1023\/a:1012730325902","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]},"assertion":[{"value":"1 September 2001","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}